Discover

HROW
Harrow Health, Inc.
39.42
1 x 39.54
2 x 39.60
bid
ask
-
1.28
3.14%
300 @ 04:00 PM
39.02 -0.40 (1.01%)
Ytd-19.55%
1y16.83%
37.70
day range
43.00
28.54
52 week range
54.85
Open39.25Prev Close40.70Low37.70High43.00Mkt Cap1.47B
Vol1.93MAvg Vol796.82KEPS0.09P/E438.00Forward P/E15.21
Beta0.25Short Ratio9.32Inst. Own58.40%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1050-d Avg40.14200-d Avg41.111yr Est67.75

HROW News

Harrow, Inc. (HROW) Q2 2026 Earnings Call Transcript
seekingalpha.com
Harrow, Inc. (HROW) Q2 2026 Earnings Call Transcript

Harrow, Inc. (HROW) Q2 2026 Earnings Call Transcript

Harrow Q2 Earnings Call Highlights
marketbeat.com
Harrow Q2 Earnings Call Highlights

Harrow NASDAQ: HROW reported second-quarter revenue of $70.7 million, up 11% from a year earlier and

OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
benzinga.com
OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tues

U.S. stock futures mostly lower. OppFi (OPFI) shares fall after missing Q2 earnings and cutting FY26

Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates
zacks.com
Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates

Harrow (HROW) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate

Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease
globenewswire.com
Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye D

NASHVILLE, Tenn., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of oph

Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026
globenewswire.com
Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026

Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on August 11, 2026 Comp

Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026
globenewswire.com
Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study

A real-world PMS study based on a large population demonstrates comparable safety profile of SB11 (B

Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting
globenewswire.com
Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meet

NASHVILLE, Tenn., July 20, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of oph

Harrow Announces Commercial Launch of BYOOVIZ® in the United States
globenewswire.com
Harrow Announces Commercial Launch of BYOOVIZ® in the United States

Expands Harrow's Growing Retina Portfolio with an Interchangeable Ranibizumab Biosimilar Expands Har

Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
businesswire.com
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harr

INCHEON, Korea--(BUSINESS WIRE)-- #Byooviz--Samsung Bioepis Co., Ltd. today announced the relaunch o

HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US
zacks.com
HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US

Harrow shares gain after relaunching Verkazia in the United States, aiming to improve access to an F

Harrow Adds Another Piece To Ophthalmology Strategy
benzinga.com
Harrow Adds Another Piece To Ophthalmology Strategy

Harrow Inc. (NASDAQ:HROW) on Wednesday announced the relaunch of VERKAZIA (cyclosporine ophthalmic e

Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare
globenewswire.com
Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis

NASHVILLE, Tenn., June 10, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of oph

Alpha Buying: When CEOs and CFOs Buy Together
benzinga.com
Alpha Buying: When CEOs and CFOs Buy Together

Harrow to Present at William Blair's 46th Annual Growth Stock Conference
globenewswire.com
Harrow to Present at William Blair's 46th Annual Growth Stock Conference

NASHVILLE, Tenn., May 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of opht

HROW Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Harrow for Potential Securities Law Violations
globenewswire.com
HROW Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Harrow for Potential Securities Law

MONSEY, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating

Harrow, Inc. (HROW) Q1 2026 Earnings Call Transcript
seekingalpha.com
Harrow, Inc. (HROW) Q1 2026 Earnings Call Transcript

Harrow, Inc. (HROW) Q1 2026 Earnings Call Transcript

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Harrow Q1 Earnings Call Highlights
marketbeat.com
Harrow Q1 Earnings Call Highlights

Harrow NASDAQ: HROW executives said the company's first-quarter results were weighed down by a discr

AST SpaceMobile Posts Downbeat Q1 Results, Joins Hims & Hers Health, Gitlab And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
AST SpaceMobile Posts Downbeat Q1 Results, Joins Hims & Hers Health, Gitlab And Other Big Stocks Mov

U.S. stock futures lower, Nasdaq down 200 points. AST SpaceMobile shares dip 11% after reporting wor

Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising gui

Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates
zacks.com
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates

Harrow (HROW) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Harrow Announces First Quarter 2026 Financial Results
globenewswire.com
Harrow Announces First Quarter 2026 Financial Results

First Quarter 2026 and Selected Highlights:  VEVYE® delivered record new and total prescription perf

Earnings Scheduled For May 11, 2026
benzinga.com
Earnings Scheduled For May 11, 2026

Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for
zacks.com
Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for

Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings

Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026
globenewswire.com
Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026

NASHVILLE, Tenn., April 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of op

State of Alaska Department of Revenue Acquires 14,065 Shares of Harrow, Inc. $HROW
defenseworld.net
State of Alaska Department of Revenue Acquires 14,065 Shares of Harrow, Inc. $HROW

State of Alaska Department of Revenue lifted its holdings in shares of Harrow, Inc. (NASDAQ: HROW) b

Harrow: Now Is The Buy Time
seekingalpha.com
Harrow: Now Is The Buy Time

Harrow has delivered a decade-long 40% CAGR in revenue, with robust operating leverage and EBITDA ma

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

MongoDB, Surgery Partners, Harrow And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
MongoDB, Surgery Partners, Harrow And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

MDB stock fell 27.2% in pre-market trading after reporting Q4 earnings of $1.65 per share, revenue o

Why Ouster Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Ouster Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Shares of Ouster Inc (NASDAQ:OUST) rose sharply in pre-market trading after the company reported bet

Yatsen Holding, Delta Air Lines, United Airlines And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Yatsen Holding, Delta Air Lines, United Airlines And Other Big Stocks Moving Lower In Monday's Pre-M

U.S. stock futures lower, Dow futures down 1%. Yatsen Holding shares fall 10.1%, while other stocks

Earnings Scheduled For March 2, 2026
benzinga.com
Earnings Scheduled For March 2, 2026

Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-M

Earnings Scheduled For November 10, 2025
benzinga.com
Earnings Scheduled For November 10, 2025

benzinga.com
Earnings Scheduled For August 11, 2025

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
benzinga.com
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

benzinga.com
Earnings Scheduled For May 8, 2025

benzinga.com
Earnings Scheduled For March 17, 2025

benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

benzinga.com
Earnings Scheduled For November 13, 2024

benzinga.com
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day

benzinga.com
Insiders Buying Greenwich LifeSciences And 2 Other Stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

benzinga.com
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wedn

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after t

benzinga.com
Earnings Scheduled For November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its

benzinga.com
Earnings Scheduled For August 9, 2023

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni

benzinga.com
Earnings Scheduled For May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings

benzinga.com
Earnings Scheduled For November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly